Eli Lilly and Company (1LLY)
MTA
Real-time Data
07:00 AM
Day's Range
1,074.6052 wk Range
595.80Overview - 1LLY - Eli Lilly and Company
Key Statistics
Valuation
Enterprise Value
866.47B
P/E (Trailing)
‪42.54‬
PEG Ratio
‪1.62‬
Price / Sales (TTM)
‪12.15‬
Price / Book
‪33.36‬
EV / EBITDA
‪24.31‬
Profitability
Gross Margin
‪85.77%‬
Profit Margin
‪33.52%‬
Operating Margin
‪54.22%‬
Return on Assets
‪20.35%‬
Return on Equity
‪102.28%‬
Ownership
Shares Outstanding
891.50M
Float
888.95M
Held by Insiders
‪0.15%‬
Held by Institutions
‪85.41%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪1,028.91‬
200-Day Avg
‪911.27‬
Dividends
Payout Ratio
‪21.69%‬
Frequency
Quarterly
Market Cap - 1LLY - Eli Lilly and Company
Peers - 1LLY - Eli Lilly and Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
Profile Summary - 1LLY - Eli Lilly and Company
About
Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing critical health needs in areas such as diabetes, oncology, immunology, neuroscience, obesity, cardiovascular diseases,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
